Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL24 (Antipressan, Atenamin, Atenix-100, Atenix-25, Atenix-50, Atenolol, Atenololum, Betacard, C07AB03, Corotenol, Duraatenolol, Esatenolol, Ibinolo, ICI 66,082, ICI 66082, ICI-66082, Juvental, Kentol, Myocord, Novaten, NSC-757832, Prenormine, Tenormin, Tenormin 25, Tenormin l.s., Totamol, Unibloc, Urosin, Vasaten) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
β1-adrenoceptor/Beta-1 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588] | ||||||||
ChEMBL | Displacement of [3H]-CGP12177 from human beta1 ADR expressed in HEK293T cell membranes after 90 mins by scintillation counting | B | 5.82 | pKi | 1513.56 | nM | Ki | J Med Chem (2018) 61: 5380-5394 [PMID:29851481] |
ChEMBL | DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) | B | 6.12 | pKi | 758 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Displacement of radiolabeled atenolol from human adrenergic beta-1 receptor | B | 6.37 | pKi | 430 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Displacement of [3H](-)-CGP12177 from human adrenergic beta1 receptor | B | 6.77 | pKi | 170 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Binding affinity to human adrenergic beta1 receptor by radioligand displacement assay | B | 6.82 | pKi | 150 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
GtoPdb | - | - | 7.6 | pKi | - | - | - |
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 525-32 [PMID:15060759]; Eur J Pharmacol (1999) 367: 431-5 [PMID:10079020]; Br J Pharmacol (2005) 144: 317-22 [PMID:15655528] |
ChEMBL | Inhibition of human beta 1 adrenergic receptor | B | 5.76 | pIC50 | 1740 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Inhibition of human alpha1 adrenoceptor | B | 5.79 | pIC50 | 1640 | nM | IC50 | Bioorg Med Chem (2010) 18: 7675-7699 [PMID:20875743] |
ChEMBL | DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) | B | 5.88 | pIC50 | 1313 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Displacement of radiolabeled atenolol from human adrenergic beta-1 receptor | B | 6.22 | pIC50 | 600 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Binding affinity to human adrenergic beta1 receptor by radioligand displacement assay | B | 6.59 | pIC50 | 260 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]CGP 12177 from human recombinant beta1 adrenergic receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method | B | 6.68 | pIC50 | 210 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Displacement of [3H](-)CGP12177 from human recombinant Beta-1 adrenergic receptor expressed in HEK293 cells | B | 6.68 | pIC50 | 210 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Percent inhibition against Beta-1 adrenergic receptor at 1 uM | B | 8.75 | pIC50 | 1.77 | nM | IC50 | J Med Chem (2005) 48: 6887-6896 [PMID:16250647] |
β1-adrenoceptor in Rat [GtoPdb: 28] [UniProtKB: P18090] | ||||||||
GtoPdb | - | - | 6.8 | pA2 | - | - | - | Life Sci (2020) 241: 117155 [PMID:31837330] |
Beta-1 adrenergic receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5471] [UniProtKB: B0FL73] | ||||||||
ChEMBL | Activity at beta-1 adrenergic receptor | B | 6.8 | pKd | 158.49 | nM | Kd | J Med Chem (1992) 35: 4676-4682 [PMID:1361581] |
ChEMBL | Antagonist activity at beta1 adrenoceptor in guinea pig atrium assessed as inhibition of isoproterenol-induced response after 20 mins | B | 7.36 | pKd | 43.65 | nM | Kd | J Med Chem (1978) 21: 1081-1084 [PMID:31474] |
ChEMBL | In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations | B | 7.62 | pKd | 23.99 | nM | Kd | J Med Chem (1983) 26: 950-957 [PMID:6134834] |
ChEMBL | In vitro inhibitory activity against beta-1 adrenergic receptor measured by inhibition of positive chronotropic effect of isoproterenolin in isolated guinea pig atria | B | 7.62 | pKd | 23.99 | nM | Kd | J Med Chem (1986) 29: 1065-1080 [PMID:2872332] |
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550] | ||||||||
ChEMBL | Displacement of [3H]DHA from inactive/G protein-uncoupled human beta2-AR expressed in CHO cell membranes assessed as intrinsic Kd by liquid scintillation counting | B | 5.92 | pKd | 1200 | nM | Kd | J Med Chem (2016) 59: 5780-5789 [PMID:27239696] |
ChEMBL | Displacement of [3H]DHA from inactive/G protein-uncoupled human beta2-AR expressed in CHO cell membranes by liquid scintillation counting | B | 6.59 | pKd | 260 | nM | Kd | J Med Chem (2016) 59: 5780-5789 [PMID:27239696] |
ChEMBL | DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) | B | 5 | pKi | 10061 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Displacement of [3H]-CGP12177 from human beta2 ADR expressed in HEK293T cell membrane after 90 mins by scintillation counting | B | 5.02 | pKi | 9549.93 | nM | Ki | J Med Chem (2018) 61: 5380-5394 [PMID:29851481] |
GtoPdb | - | - | 6 | pKi | - | - | - |
Eur J Pharmacol (1999) 367: 431-5 [PMID:10079020]; Br J Pharmacol (2005) 144: 317-22 [PMID:15655528] |
ChEMBL | DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) | B | 4.83 | pIC50 | 14634 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Beta-2 adrenergic receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5414] [UniProtKB: Q8K4Z4] | ||||||||
ChEMBL | Antagonist activity at beta2 adrenoceptor in guinea pig trachea assessed as inhibition of isoproterenol-induced response after 20 mins | B | 5.9 | pKd | 1258.93 | nM | Kd | J Med Chem (1978) 21: 1081-1084 [PMID:31474] |
ChEMBL | In vitro beta-2 adrenergic receptor activity was determined by measuring inhibition of the isoproterenol induced relaxation in isolated guinea pig tracheal chains contracted with PGF2-alpha | B | 5.93 | pKd | 1174.9 | nM | Kd | J Med Chem (1983) 26: 950-957 [PMID:6134834] |
ChEMBL | In vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea | B | 5.93 | pKd | 1174.9 | nM | Kd | J Med Chem (1986) 29: 1065-1080 [PMID:2872332] |
5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL273] [GtoPdb: 1] [UniProtKB: P19327] | ||||||||
ChEMBL | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement | B | 5 | pKi | 10000 | nM | Ki | J Med Chem (1996) 39: 126-134 [PMID:8568799] |
Urease in Canavalia ensiformis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4161] [UniProtKB: P07374] | ||||||||
ChEMBL | Inhibition of jack bean urease assessed as reduction on ammonia production using urea as substrate preincubated for 15 mins followed by substrate addition and measured after 15 mins by indophenol method | B | 4.19 | pIC50 | 64360 | nM | IC50 | Eur J Med Chem (2022) 234: 114273-114273 [PMID:35305460] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]